Combination effect of pectasol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU-145 and lncap prostate cancer cell lines

Cell Biology International

Volumn 36, Issue 7, 2012, Pages 601-610

  Tehranian, Najmeh ^a   Sepehri, Houri ^a   Mehdipour, Parvin ^b   Biramijamal, Firouzeh ^c   Hossein Nezhad, Arash ^d,e   Sarrafnejad, Abdolfattah ^e   Hajizadeh, Ebrahim ^f  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Doxorubicin (dox); Gene Expression; Lncap); Pectasol; Prostate cancer (pca) cell lines (du 145; Protein Expression; Viability

Indexed keywords

DOXORUBICIN; PECTASOL; PECTIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALE; MONOTHERAPY; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOXORUBICIN; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MALE; PECTINS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862845707     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110309     Document Type: Article

References (22)

1. Bar-On O, Shapira M, Hershko DD. 2007 Differential effect of doxorubicin treatment on cell cycle arrest and SKP2 expression in breast Cancer cells. Anticancer Drugs, 18, 1113-21.
2. Collins L, Zhu T, Guo J, Xiao ZJ, Chen C-Y. 2006 Phellinus Linteus sensitises apoptosis induced by doxorubicin in prostate cancer. Br J Cancer, 95, 282-8.
3. Elsadek B, Graeser R, Esser N, Schäfer-Obodozie C, Tsurumi C, Abu Ajaj K. 2011 In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP). Prostate Cancer Prostatic Dis, 14, 14-21.
4. Glinsky VV, Raz A. 2009 Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. Carbohydr Res, 344, 1788-91.
5. Grassilli E, Ballabeni A, Maellaro E, Del Bello B. 2004 Loss of MYC confers resistance to Doxorubicin-induced apoptosis by preventing the activation of multiple serine protease- and caspase-mediated pathways. J Biol Chem, 279, 21318-26.
6. Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ. 2003 Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis, 6, 301-4.
7. Jackson CL, Dreaden TM, Theobald LK, Tran NM, Beal TL, Eid M. 2007 Pectin induces apoptosis in human prostatic cancer cells: correlation of apoptotic function with pectin structure. Glycobiology, 17, 805-19.
8. Johnson KD, Glinskii OV, Mossin VV, Turk JR. 2007 Galactin-3 as a potential therapeutic target in tumors arising from malignant. Neoplasia, 9, 662-70.
9. Kang J, Bu J, Hao Y, Chen F. 2005 Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. Prostate Cancer Prostatic Dis, 8, 274-9.
10. Kim DW, Kim KO, Shin MJ, 2009 Ha JH. siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in Pglycoprotein expressing chondrosarcoma cells. Mol. Cancer, 8, 28.
11. Manna SK, Gangadharan C, Edupalli D. 2010 Ras puts brake doxorubicin mediated cell death in p53 expressing cells. J. Biol. Chem, 286, 7339-47.
12. Mantena SK, Sharma SD, Katiyar SK. Berberine, 2006 a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther, 5, 296-308.
13. Neheme A, Varadarajan P, Sellakumar G, Gerhold M, Niedner H, Zhang 2001 Q et al. Modulation of docetaxel induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells. Br J Cancer, 84, 1571-1576.
14. Opel D, Westhoff M, Bender A, Braun V, Debatin K, 2008 Fulda V. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor and drug induced apoptosis. Am Assoc Cancer Res, 68, 6271-80.
15. Pulukuri S, Knost J, Estes N, Rao JS. 2009 Small interfering RNA (siRNA)-directed knockdown of uracil DNA glycosylase induces apoptosis and sensitizes human prostate cancer cells to genotoxic stres. Mol Cancer Res, 7, 1285-93.
16. Rabi T, 2009 Bishayee A. d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: generation of reactive oxygen species and induction of apoptosis. J. Carcinog, 8-9.
17. Sanches C, Mendoza P, Contreras HR, Vergara J. 2009 Expression of resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs. Prostate, 69, 1448-59.
18. Servida F, Lecis D, Scavullo C. 2011 Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis. Invest New Drugs, 29, 1264-75.
19. Tyagi AK, Singh RP, Agrawal C, Chan DCF, Agrawal R. 2002 Silibinin strongly synergizes human prostate carcinoma DU-145 cells to doxorubicin-induced growth inhibition, G2-M Arrest, and apoptosis. Clin Cancer Res, 8, 3512-9.
20. Wu XX, Kakehi Y, Mizutani Y, Kamoto T, Kinoshita H, Isogawa Y. 2002 Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. Int J Oncol, 20, 949-54.
21. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B. 2004 Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. J Biol Chem, 279, 25535-43.
22. Yan J, Katz A. 2010 PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgen-dependent and -independent prostate cancer cells. Integr Cancer Ther, 9, 197-203.